Search

Your search keyword '"Severson KJ"' showing total 5 results
Start Over Author "Severson KJ" Publisher mosby
5 results on '"Severson KJ"'

1. Necrobiosis lipoidica-associated cutaneous malignancy.

Author

Harvey JA, Severson KJ, Brumfiel CM, Patel MH, Butterfield RJ, Nelson SA, Sekulic A, Pittelkow MR, and Mangold AR

Subjects
Humans, Necrobiosis Lipoidica complications, Necrobiosis Lipoidica diagnosis, Necrobiosis Lipoidica pathology, Skin Neoplasms diagnosis
Abstract

Competing Interests: Conflicts of interest None disclosed.

Published
2022
Full Text
View/download PDF

3. Primary cutaneous CD4 + small/medium T-cell lymphoproliferative disorder: Diagnosis and management.

Author

Besch-Stokes JG, Costello CM, Severson KJ, Bhullar P, Montoya J, Butterfield RJ, DiCaudo DJ, Comfere N, Sluzevich J, Rule W, Craig FE, Rosenthal A, Pittelkow MR, and Mangold AR

Subjects
CD4-Positive T-Lymphocytes, Humans, Skin, Lymphoma, T-Cell, Cutaneous diagnosis, Lymphoma, T-Cell, Cutaneous therapy, Lymphoproliferative Disorders diagnosis, Lymphoproliferative Disorders therapy, Skin Neoplasms diagnosis, Skin Neoplasms therapy
Abstract

Competing Interests: Conflicts of interest Dr Mangold reports personal fees from Kirin and grants from Elorac, MiRagen, Solagenix, DUSA/Sun Pharma, and Acetilion, outside the submitted work. Drs Costello, DiCaudo, Comfere, Sluzevich, Rule, Craig, Rosenthal, and Pittelkow and authors Besch-Stokes, Severson, Bhullar, Montoya, and Butterfield have no conflicts of interest to declare.

Published
2022
Full Text
View/download PDF

4. Comorbidities and diabetic complications in patients with necrobiosis lipoidica.

Author

Severson KJ, Patel MH, Brumfiel CM, Breen I, Butterfield RJ, Nelson SA, Sekulic A, Pittelkow MR, and Mangold AR

Subjects
Comorbidity, Humans, Diabetes Complications epidemiology, Diabetes Mellitus, Type 1 complications, Necrobiosis Lipoidica complications, Necrobiosis Lipoidica epidemiology
Abstract

Competing Interests: Conflicts of interest Dr Mangold is a clinical investigator at Eli Lilly, Novartis, Sun Pharmaceutical, Pfizer, Acetilion, Incyte, Corbus, MiRagen, Solagenix, and Regeneron. He is also a current advisor at Eli Lilly and Kirin. Authors Severson, Patel, Brumfiel, Breen, Butterfield, Dr Nelson, Dr Sekulic, and Dr Pittelkow have no conflicts of interest to declare.

Published
2022
Full Text
View/download PDF

5. Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study.

Author

Severson KJ, Cumsky HJL, Brumfiel CM, Janeczek MC, Ginos BF, Kosiorek HE, Besch-Stokes J, Patel MH, Rule WG, DiCaudo DJ, Rosenthal AC, Pittelkow MR, and Mangold AR

Subjects
Aminolevulinic Acid therapeutic use, Humans, Photosensitizing Agents therapeutic use, Prospective Studies, Mycosis Fungoides drug therapy, Photochemotherapy, Skin Neoplasms drug therapy
Abstract

Competing Interests: Conflicts of interest Dr Mangold is an investigator for multiple studies in mycosis fungoides sponsored by Solagenix, MiRagen, Sun Pharma, and Elorac, and also serves on an advisory board for Kirin. Authors Severson, Brumfiel, Ginos, Kosiorek, Besch-Stokes, and Patel, and Drs Cumsky, Janeczek, Rule, DiCaudo, Rosenthal, and Pittelkow have no conflicts of interest to declare.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results